To evaluate, in different GC cohorts, protein expression of multiple immunotherapy targets, besides PD-L1, would be crucial to integrate gene and protein expression data, as well to explore the topographic distribution (i.e., cancer cells versus TME immune cells) of different biomarkers. The gene discussed is CD274; the disease is cancer.